Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Celsius Herbs Brings Plant-Based Care to People and Pets
Today 13:52 EDT
Via
Press Release Distribution Service
Exposures
COVID-19
BioNTech Has More Cancer Drugs in Late-Stage Trials Than Most Investors Realize. Is It a Buy Under $100?
↗
Today 12:35 EDT
Via
The Motley Fool
Tickers
BNTX
Exposures
COVID-19
Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.
↗
Today 9:35 EDT
Via
The Motley Fool
Topics
Intellectual Property
Tickers
LLY
PFE
Exposures
COVID-19
Intellectual Property
1 Growth Stock with Explosive Upside and 2 That Underwhelm
Today 0:32 EDT
Via
StockStory
Tickers
ENVA
LAUR
P
Exposures
COVID-19
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Today 0:31 EDT
Via
StockStory
Tickers
CSCO
GHM
NET
WSBC
Exposures
COVID-19
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
October 07, 2026
Via
StockStory
Topics
Artificial Intelligence
Tickers
BIIB
GILD
MYGN
Exposures
Artificial Intelligence
COVID-19
A Look Back at IT Distribution & Solutions Stocks’ Q2 Earnings: Connection (NASDAQ:CNXN) Vs The Rest Of The Pack
October 07, 2026
Via
StockStory
Topics
Economy
Tickers
AVT
CNXN
Exposures
COVID-19
Supply Chain
Pfizer Stock: Buy, Sell, or Hold?
↗
October 07, 2026
Via
The Motley Fool
Topics
Intellectual Property
Tickers
PFE
Exposures
COVID-19
Intellectual Property
The Federal Reserve Is Raising Interest Rates. Here's What History Says That Means for Investors.
↗
October 07, 2026
Via
The Motley Fool
Topics
Economy
Exposures
COVID-19
Economy
Interest Rates
Why QXO Sank Today
↗
October 07, 2026
Via
The Motley Fool
Tickers
GXO
QXO
RY
TSX:RY
Exposures
COVID-19
Anatara Medicine Delivers Personalized Therapeutic Plasma Exchange in San Francisco, CA
October 07, 2026
Via
GetFeatured
Exposures
COVID-19
All It Takes Is $15,182 Invested in This High-Yield Dividend Stock to Generate Over $1,000 in Yearly Dividends
↗
October 07, 2026
Via
The Motley Fool
Tickers
AMC
EPR
FUN
Exposures
COVID-19
Bank OZK Boosted Its Dividend and Is Poised to Keep Raising It
↗
October 07, 2026
Via
The Motley Fool
Topics
Economy
Tickers
OZK
USB
Exposures
COVID-19
Economy
10-Year Treasuries Yield 5.3%; Schwab's Dividend ETF Yields 3.4%. Which One Should Income Investors Buy?
↗
October 07, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
Tickers
SCHD
SCHW
Exposures
COVID-19
Debt Markets
Legal
History Says There Are $8.44 Trillion Reasons the Trump Bull Market Is Running on Borrowed Time
↗
October 07, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Government
Exposures
Artificial Intelligence
COVID-19
Interest Rates
Costco's Cash Pile Keeps Building. Could a Special Dividend Come in the Final 3 Months of the Year?
↗
October 06, 2026
Via
The Motley Fool
Tickers
COST
Exposures
COVID-19
History Says This 1 Move Will Determine Whether Your Investments Survive a Bear Market
↗
October 06, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Stocks
Tickers
IMCG
IVE
IVW
QQQ
VB
VBK
Exposures
COVID-19
Interest Rates
US Equities
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present at NIBA 153rd Investment Conference
October 06, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
NNVC
Exposures
COVID-19
Intellectual Property
Wall Street Is Worried About a Market Crash. 75 Years of History Says Investors Should Be Watching Something Else.
↗
October 06, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Economy
Tickers
VOO
VTI
Exposures
COVID-19
Debt Markets
Interest Rates
2 Growth Stocks to Add to Your Roster and 1 We Avoid
October 06, 2026
Via
StockStory
Tickers
HOOD
HUBS
WAL
Exposures
COVID-19
The 30-Year Treasury Yield Just Hit a 24-Year High, and It Could Signal a Warning Sign for the Stock Market
↗
October 05, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Bonds
Credit Cards
Exposures
Artificial Intelligence
COVID-19
Debt Markets
1 Stat That Makes Coca-Cola Hard to Ignore in October
↗
October 05, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
KO
Exposures
COVID-19
Financial
BioMedNewsBreaks – NanoViricides (NYSE American: NNVC) Provides Update on Phase II Ebola Trial of NV-387 Oral Gummies
October 05, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
NNVC
Exposures
COVID-19
Intellectual Property
Palantir's 93% Revenue Growth Is Colliding With Michael Burry's Bear Case -- Here's Who Has the Stronger Argument
↗
October 05, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Tickers
PLTR
PYPL
Exposures
Artificial Intelligence
COVID-19
Warren Buffett Has Only Recommended 1 Investment in Over 60 Years, and It's Never Lost Money (but There's a Catch)
↗
October 05, 2026
Via
The Motley Fool
Topics
ETFs
Tickers
BRK-A
BRK-B
ORCL
SPY
VOO
Exposures
COVID-19
President Donald Trump's Proposed $5,000 "Trump Dividend" Could Epically Backfire for 2 Key Reasons
↗
October 05, 2026
Via
The Motley Fool
Topics
Economy
Government
Stocks
Exposures
COVID-19
Economy
Interest Rates
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
October 05, 2026
Via
StockStory
Topics
Economy
Tickers
AORT
MRNA
PLUS
Exposures
COVID-19
Supply Chain
2 Growth Stocks with All-Star Potential and 1 We Brush Off
October 05, 2026
Via
StockStory
Tickers
AMSC
CSCO
LLY
VIAV
Exposures
COVID-19
AEW UK REIT Eyes £200M Pipeline as It Prepares for Debt Refinancing
↗
October 05, 2026
Via
MarketBeat
Exposures
COVID-19
Invivyd’s VYD2311 Phase III Study Meets Safety Goals, Eyes FDA Accelerated Approval
↗
October 04, 2026
Via
MarketBeat
Tickers
ARM
IVVD
Exposures
COVID-19
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.